- Home
- APM vs CHNR Comparison
APM vs CHNR Comparison
Compare APM & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- CHNR
- Stock Information
- Founded
- APM 2010
- CHNR N/A
- Country
- APM United Kingdom
- CHNR Hong Kong
- Employees
- APM N/A
- CHNR N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- APM Health Care
- CHNR Basic Materials
- Exchange
- APM Nasdaq
- CHNR Nasdaq
- Market Cap
- APM 5.6M
- CHNR 4.8M
- IPO Year
- APM 2018
- CHNR 1995
- Fundamental
- Price
- APM $0.99
- CHNR $0.57
- Analyst Decision
- APM
- CHNR
- Analyst Count
- APM 0
- CHNR 0
- Target Price
- APM N/A
- CHNR N/A
- AVG Volume (30 Days)
- APM 138.3K
- CHNR 13.5K
- Earning Date
- APM 05-06-2025
- CHNR 01-01-0001
- Dividend Yield
- APM N/A
- CHNR N/A
- EPS Growth
- APM N/A
- CHNR N/A
- EPS
- APM 0.00
- CHNR N/A
- Revenue
- APM N/A
- CHNR N/A
- Revenue This Year
- APM $157,729.10
- CHNR N/A
- Revenue Next Year
- APM N/A
- CHNR N/A
- P/E Ratio
- APM $270.99
- CHNR N/A
- Revenue Growth
- APM N/A
- CHNR N/A
- 52 Week Low
- APM $0.46
- CHNR $0.45
- 52 Week High
- APM $7.49
- CHNR $1.14
- Technical
- Relative Strength Index (RSI)
- APM 51.54
- CHNR 55.22
- Support Level
- APM $0.79
- CHNR $0.45
- Resistance Level
- APM $0.97
- CHNR $0.55
- Average True Range (ATR)
- APM 0.12
- CHNR 0.05
- MACD
- APM 0.02
- CHNR 0.01
- Stochastic Oscillator
- APM 33.74
- CHNR 78.20
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.